0
Zynerba Pharmaceuticals, Inc. Banner Image

Zynerba Pharmaceuticals, Inc. has reached its limit for free report views

Work for Zynerba Pharmaceuticals, Inc.? Upgrade Your Profile and unlock all your annual reports.

Zynerba Pharmaceuticals, Inc.

  • Ticker ZYNE
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Zynerba Pharmaceuticals, Inc. Logo Image
  • 11-50 Employees
  • Based in Devon, Pennsylvania
Zynerba (NASDAQ: ZYNE) is dedicated to improving the lives of people with rare and near rare neuropsychiatric disorders where there is a high unmet medical need by pioneering the development and commercialization of next-generation pharmaceutically-produced cannabinoid therapeutics formulated for transdermal delivery. Cannabinoids interact with specific receptors throughout the body toMore produce pharmacologic effects, primarily in the CNS and immune systems.
Zynerba Pharmaceuticals, Inc.

Most Recent Annual Report

Zynerba Pharmaceuticals, Inc. MOST RECENT 2019 Annual Report and Form 10K

Report Locked. Zynerba Pharmaceuticals, Inc. has reached its limit for free report views.

Older/Archived Annual Reports